Baidu
map

神经科指南

订阅

MedSci主页 / 所有栏目 / 神经科指南

中国脑小血管病诊治专家共识2021

2021-07-25 中国研究型医院学会 中国卒中杂志.2021.16(7):716-726.

脑小血管病

脑小血管病（cerebral small-vesseldisease，CSVD）是严重危害我国人民健康的常见疾病，由于多起病隐匿，容易被患者甚至临床医师忽视。自2015年《中国脑小血管病诊治共识》发表

中文标题：

中国脑小血管病诊治专家共识2021

发布机构：

中国研究型医院学会

发布日期：

2021-07-25

简要介绍：

脑小血管病（cerebral small-vesseldisease，CSVD）是严重危害我国人民健康的常见疾病，由于多起病隐匿，容易被患者甚至临床医师忽视。自2015年《中国脑小血管病诊治共识》发表以来，人们对CSVD的认识有了显著提高。近年来，随着研究的深入，在CSVD危险因素、发病机制、临床表现以及评价体系等方面有了快速进展。基于此背景，中国医院研究型学会脑小血管病专家委员会结合国内外最新研究成果，编写了《中国脑小血管病诊治专家共识2021》，以体现CSVD领域研究的最新进展，为CSVD的诊断和治疗提供指导。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=中国脑小血管病诊治专家共识2021_胡文立.pdf)] GetToolGuiderByIdResponse(projectId=1, id=572311c0021a194c, title=中国脑小血管病诊治专家共识2021, enTitle=, guiderFrom=中国卒中杂志.2021.16(7):716-726., authorId=0, author=, summary=脑小血管病（cerebral small-vesseldisease，CSVD）是严重危害我国人民健康的常见疾病，由于多起病隐匿，容易被患者甚至临床医师忽视。自2015年《中国脑小血管病诊治共识》发表, cover=https://img.medsci.cn/2021731/1627739154759_2020535.jpg, journalId=0, articlesId=null, associationId=1023, associationName=中国研究型医院学会, associationIntro=中国研究型医院学会，英文名称Chinese Research Hospital Association（CRHA），是经国家民政部正式批复并登记注册的全国性一级学会，是独立的法人社团。中国研究型医院学会是由以探索和建设研究型医院为目标的具有医疗服务、科学研究和临床教学&ldquo;三位一体&rdquo;功能的医疗机构，以及从事研究型医院理论与实践研究的人员自愿结成的全国性、专业性、学术性、非营利性社会组织。, copyright=0, guiderPublishedTime=Sun Jul 25 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>脑小血管病（cerebral small-vesseldisease，CSVD）是严重危害我国人民健康的常见疾病，由于多起病隐匿，容易被患者甚至临床医师忽视。自2015年《中国脑小血管病诊治共识》发表以来，人们对CSVD的认识有了显著提高。近年来，随着研究的深入，在CSVD危险因素、发病机制、临床表现以及评价体系等方面有了快速进展。基于此背景，中国医院研究型学会脑小血管病专家委员会结合国内外最新研究成果，编写了《中国脑小血管病诊治专家共识2021》，以体现CSVD领域研究的最新进展，为CSVD的诊断和治疗提供指导。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=4297, tagName=脑小血管病)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=4297, guiderKeyword=脑小血管病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10420, appHits=684, showAppHits=0, pcHits=1426, showPcHits=9734, likes=6, shares=67, comments=32, approvalStatus=1, publishedTime=Sat Jul 31 22:51:53 CST 2021, publishedTimeString=2021-07-25, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Jul 31 21:46:01 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 21:48:55 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国脑小血管病诊治专家共识2021_胡文立.pdf)])
中国脑小血管病诊治专家共识2021_胡文立.pdf
下载请点击：
评论区 (30)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1219972, encodeId=3f5412199e24e, content=下载了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211030/727082c36c794e7a9cc18aad6a2886d1/d8e51d61f5f74b299541d33450410b09.jpg, createdBy=26f72982264, createdName=海阔天空Sin, createdTime=Mon May 16 11:39:07 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219330, encodeId=840f121933001, content=非常好！学习了之后很有收获！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211030/727082c36c794e7a9cc18aad6a2886d1/d8e51d61f5f74b299541d33450410b09.jpg, createdBy=26f72982264, createdName=海阔天空Sin, createdTime=Fri May 13 12:37:59 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194614, encodeId=f53311946140a, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5825620878, createdName=ms4000000846621247, createdTime=Thu Feb 17 22:18:19 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081228, encodeId=2bb5108122899, content=新指南来学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=452f2351029, createdName=122af4aam61暂无昵称, createdTime=Fri Dec 17 18:59:06 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080010, encodeId=314e1080010d3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=56371965915, createdName=珠妞妞, createdTime=Tue Dec 14 17:09:57 CST 2021, time=2021-12-14, status=1, ipAttribution=)]
    2022-05-16 海阔天空Sin

    下载了！

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1219972, encodeId=3f5412199e24e, content=下载了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211030/727082c36c794e7a9cc18aad6a2886d1/d8e51d61f5f74b299541d33450410b09.jpg, createdBy=26f72982264, createdName=海阔天空Sin, createdTime=Mon May 16 11:39:07 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219330, encodeId=840f121933001, content=非常好！学习了之后很有收获！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211030/727082c36c794e7a9cc18aad6a2886d1/d8e51d61f5f74b299541d33450410b09.jpg, createdBy=26f72982264, createdName=海阔天空Sin, createdTime=Fri May 13 12:37:59 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194614, encodeId=f53311946140a, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5825620878, createdName=ms4000000846621247, createdTime=Thu Feb 17 22:18:19 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081228, encodeId=2bb5108122899, content=新指南来学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=452f2351029, createdName=122af4aam61暂无昵称, createdTime=Fri Dec 17 18:59:06 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080010, encodeId=314e1080010d3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=56371965915, createdName=珠妞妞, createdTime=Tue Dec 14 17:09:57 CST 2021, time=2021-12-14, status=1, ipAttribution=)]
    2022-05-13 海阔天空Sin

    非常好！学习了之后很有收获！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1219972, encodeId=3f5412199e24e, content=下载了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211030/727082c36c794e7a9cc18aad6a2886d1/d8e51d61f5f74b299541d33450410b09.jpg, createdBy=26f72982264, createdName=海阔天空Sin, createdTime=Mon May 16 11:39:07 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219330, encodeId=840f121933001, content=非常好！学习了之后很有收获！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211030/727082c36c794e7a9cc18aad6a2886d1/d8e51d61f5f74b299541d33450410b09.jpg, createdBy=26f72982264, createdName=海阔天空Sin, createdTime=Fri May 13 12:37:59 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194614, encodeId=f53311946140a, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5825620878, createdName=ms4000000846621247, createdTime=Thu Feb 17 22:18:19 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081228, encodeId=2bb5108122899, content=新指南来学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=452f2351029, createdName=122af4aam61暂无昵称, createdTime=Fri Dec 17 18:59:06 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080010, encodeId=314e1080010d3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=56371965915, createdName=珠妞妞, createdTime=Tue Dec 14 17:09:57 CST 2021, time=2021-12-14, status=1, ipAttribution=)]
    2022-02-17 ms4000000846621247

    好好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1219972, encodeId=3f5412199e24e, content=下载了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211030/727082c36c794e7a9cc18aad6a2886d1/d8e51d61f5f74b299541d33450410b09.jpg, createdBy=26f72982264, createdName=海阔天空Sin, createdTime=Mon May 16 11:39:07 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219330, encodeId=840f121933001, content=非常好！学习了之后很有收获！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211030/727082c36c794e7a9cc18aad6a2886d1/d8e51d61f5f74b299541d33450410b09.jpg, createdBy=26f72982264, createdName=海阔天空Sin, createdTime=Fri May 13 12:37:59 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194614, encodeId=f53311946140a, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5825620878, createdName=ms4000000846621247, createdTime=Thu Feb 17 22:18:19 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081228, encodeId=2bb5108122899, content=新指南来学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=452f2351029, createdName=122af4aam61暂无昵称, createdTime=Fri Dec 17 18:59:06 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080010, encodeId=314e1080010d3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=56371965915, createdName=珠妞妞, createdTime=Tue Dec 14 17:09:57 CST 2021, time=2021-12-14, status=1, ipAttribution=)]
    2021-12-17 122af4aam61暂无昵称

    新指南来学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1219972, encodeId=3f5412199e24e, content=下载了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211030/727082c36c794e7a9cc18aad6a2886d1/d8e51d61f5f74b299541d33450410b09.jpg, createdBy=26f72982264, createdName=海阔天空Sin, createdTime=Mon May 16 11:39:07 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219330, encodeId=840f121933001, content=非常好！学习了之后很有收获！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211030/727082c36c794e7a9cc18aad6a2886d1/d8e51d61f5f74b299541d33450410b09.jpg, createdBy=26f72982264, createdName=海阔天空Sin, createdTime=Fri May 13 12:37:59 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194614, encodeId=f53311946140a, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5825620878, createdName=ms4000000846621247, createdTime=Thu Feb 17 22:18:19 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081228, encodeId=2bb5108122899, content=新指南来学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=452f2351029, createdName=122af4aam61暂无昵称, createdTime=Fri Dec 17 18:59:06 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080010, encodeId=314e1080010d3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=56371965915, createdName=珠妞妞, createdTime=Tue Dec 14 17:09:57 CST 2021, time=2021-12-14, status=1, ipAttribution=)]
    2021-12-14 珠妞妞

    学习了

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

脑小血管病相关认知功能障碍中国诊疗指南（2019）

中华医学会老年医学分会 · 2019-04-20

脑小血管病转化医学研究中国专家共识

中国神经内科相关专家小组（统称） · 2018-08-30

拓展阅读

脑小血管病转化医学研究中国专家共识

中国神经内科相关专家小组（统称） · 2018-08-30

脑小血管病相关认知功能障碍中国诊疗指南（2019）

中华医学会老年医学分会 · 2019-04-20

脑小血管病国际影像标准2更新要点解读

国家神经疾病医学中心 · 2023-10-20

脑小血管病影像学诊断标准的更新解读

暂未更新 · 2023-11-25

中国脑小血管病的神经影像学诊断标准及名词标准化定义——来自中国卒中学会的专家共识

暂未更新 · 2024-04-20

Baidu
map
Baidu
map
Baidu
map